Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Drugs in Pipeline
3
Phase 3 Programs
0
Upcoming Catalysts
2
Next Catalyst
Jun 27, 2026
27w| Drug Name | Phase |
|---|---|
WVE-006 | Phase 2 |
WVE-N531 | Phase 2 |
SAD: 30mg WVE-003 | Phase 2 |
2 upcoming, 0 past
Primary completion for WVE-N531 trial (NCT04906460) in Duchenne Muscular Dystrophy
SourcePrimary completion for WVE-006 trial (NCT06405633) in Alpha-1 Antitrypsin Deficiency
Source